We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Dechra Pharmaceuticals Plc | LSE:DPH | London | Ordinary Share | GB0009633180 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 3,866.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMDPH
RNS Number : 6734G
Dechra Pharmaceuticals PLC
05 March 2018
5 March 2018
Dechra(R) Pharmaceuticals PLC
(Dechra or the Company)
LEI: 213800J4UVB5OWG8VX82
Notification and public disclosure of transactions by
persons discharging managerial responsibilities (PDMRs)
The Company announces that on 2 March 2018 the following Directors were granted awards over Ordinary Shares of 1 pence each in the Company under the Dechra 2017 Long Term Incentive:
Hot Features
Premium
Name of individual Director Type of award Number of
shares subject
to award
-------------------- ---------- ---------------- ----------------
LTIP Award
- nil cost
Ian Page* Director option 39,904
-------------------- ---------- ---------------- ----------------
LTIP Award
- nil cost
Richard Cotton* Director option 21,473
-------------------- ---------- ---------------- ----------------
LTIP Award
- conditional
Tony Griffin Director award 12,099
-------------------- ---------- ---------------- ----------------
*Each of Ian Page and Richard Cotton has also been granted a tax qualifying option over 1,197 shares at an exercise price of GBP25.06 as part of their LTIP award. These tax qualifying options are linked to the nil cost option such that, at the time of exercise, to the extent that there is a gain in the tax qualifying option, the nil cost option will be forfeited to the value of that gain.
The vesting of all the above awards is subject to the achievement of performance targets. In respect of these grants the performance conditions will be determined by reference to the Company's Earnings per Share (EPS) and its Total Shareholder Return (TSR) relative to constituent companies of the FTSE 250 index (excluding investment trusts) over a three year performance period. Both the EPS and TSR elements will be subject to an additional Return on Capital Employed (ROCE) performance condition. If the ROCE performance condition is not met, then the LTIP Awards will lapse in full.
The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.
Notification of Dealing Form
1. Details of the Person Discharging Managerial
Responsibility ("PDMR")/person closely
associated with them ("PCA")
--- -------------------------------------------------------------
a) Name Ian Page
--- ----------------------------- ------------------------------
2. Reason for the notification
--- -------------------------------------------------------------
a) Position/status Director
--- ----------------------------- ------------------------------
b) Initial notification/ Initial Notification
amendment
--- ----------------------------- ------------------------------
3. Details of the Issuer
--- -------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
--- ----------------------------- ------------------------------
b) LEI code 213800J4UVB5OWG8VX82
--- ----------------------------- ------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -------------------------------------------------------------
a) Description Ordinary Shares of 1 pence
of the financial each
instrument
ISIN: GB0009633180
Identification
code
--- ----------------------------- ------------------------------
b) Nature of Grant of awards over Ordinary
the transaction Shares under the Company's
Long Term Incentive Plan
--- ----------------------------- ------------------------------
c) Price(s) and Nil cost option
volumes(s) Price Volume
---------------- -------
Nil cost award 39,904
---------------- -------
Tax qualifying option
Price Volume
------------------ -------
GBP25.06 (per
Ordinary Share
exercise price) 1,197
------------------ -------
--- ----------------------------- ------------------------------
d) Aggregated
information
* Aggregate volume Awards granted over 41,101
Ordinary Shares in total
N/A
* Price
--- ----------------------------- ------------------------------
e) Date of the 2018-03-02
transaction
--- ----------------------------- ------------------------------
f) Place of the Outside a trading venue
transaction
--- ----------------------------- ------------------------------
1. Details of the Person Discharging Managerial
Responsibility ("PDMR")/person closely
associated with them ("PCA")
--- -------------------------------------------------------------
a) Name Richard Cotton
--- ----------------------------- ------------------------------
2. Reason for the notification
--- -------------------------------------------------------------
a) Position/status Director
--- ----------------------------- ------------------------------
b) Initial notification/ Initial Notification
amendment
--- ----------------------------- ------------------------------
3. Details of the Issuer
--- -------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
--- ----------------------------- ------------------------------
b) LEI code 213800J4UVB5OWG8VX82
--- ----------------------------- ------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -------------------------------------------------------------
a) Description Ordinary Shares of 1 pence
of the financial each
instrument
ISIN: GB0009633180
Identification
code
--- ----------------------------- ------------------------------
b) Nature of Grant of awards over Ordinary
the transaction Shares under the Company's
Long Term Incentive Plan
--- ----------------------------- ------------------------------
c) Price(s) and LTIP Award
volumes(s) Price Volume
---------------- -------
Nil cost award 21,473
---------------- -------
Tax qualifying option
Price Volume
------------------ -------
GBP25.06 (per
Ordinary Share
exercise price) 1,197
------------------ -------
--- ----------------------------- ------------------------------
d) Aggregated
information
* Aggregate volume Awards granted over 22,670
Ordinary Shares in total
N/A
* Price
--- ----------------------------- ------------------------------
e) Date of the 2018-03-02
transaction
--- ----------------------------- ------------------------------
f) Place of the Outside a trading venue
transaction
--- ----------------------------- ------------------------------
1. Details of the Person Discharging Managerial
Responsibility ("PDMR")/person closely
associated with them ("PCA")
--- ---------------------------------------------------------------
a) Name Tony Griffin
--- ----------------------------- --------------------------------
2. Reason for the notification
--- ---------------------------------------------------------------
a) Position/status Director
--- ----------------------------- --------------------------------
b) Initial notification/ Initial Notification
amendment
--- ----------------------------- --------------------------------
3. Details of the Issuer
--- ---------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
--- ----------------------------- --------------------------------
b) LEI code 213800J4UVB5OWG8VX82
--- ----------------------------- --------------------------------
4. Details of the transaction(s): section
to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- ---------------------------------------------------------------
a) Description Ordinary Shares of 1 pence
of the financial each
instrument
ISIN: GB0009633180
Identification
code
--- ----------------------------- --------------------------------
b) Nature of Grant of an award over Ordinary
the transaction Shares under the Company's
Long Term Incentive Plan
--- ----------------------------- --------------------------------
c) Price(s) and Conditional award
volumes(s) Price Volume
---------------- -------
Nil cost award 12,099
---------------- -------
--- ----------------------------- --------------------------------
d) Aggregated
information
* Aggregate volume
N/A
* Price
--- ----------------------------- --------------------------------
e) Date of the 2018-03-02
transaction
--- ----------------------------- --------------------------------
f) Place of the Outside a trading venue
transaction
--- ----------------------------- --------------------------------
For further information, please contact:
Melanie Hall, Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHFKPDNCBKKCNK
(END) Dow Jones Newswires
March 05, 2018 04:40 ET (09:40 GMT)
1 Year Dechra Pharmaceuticals Chart |
1 Month Dechra Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
